Greg Zante

Companies

• Viking TherapeuticsChief financial officer Jan 6, 2021 to now¹
• SANGAMO THERAPEUTICS, INCSr. Director Finance & Admin Jun 5, 2006 to Mar 12, 2008²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• VTViking Therapeutics VKTX212,204 shares³$5.3M at $25.11Jul 29, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 29, 2026Sold 21,217 shares at $33.47 of Viking Therapeutics³
• Jul 28, 2026Granted 31,667 shares of Viking Therapeutics³
• Jan 5, 2026Sold 1,500 shares at $32.09 of Viking Therapeutics⁴
• Jan 5, 2026Sold 10,300 shares at $34.24 of Viking Therapeutics⁴
• Jan 5, 2026Sold 13,900 shares at $33.38 of Viking Therapeutics⁴
• Jan 5, 2026Sold 31,961 shares at $32.30 of Viking Therapeutics⁴
• Jan 2, 2026Granted 32,049 shares of Viking Therapeutics⁴
• Jan 2, 2026Granted 41,000 shares of Viking Therapeutics⁴
• Oct 28, 2025Sold 6,185 shares at $35.00 of Viking Therapeutics⁵
• Oct 27, 2025Granted 11,117 shares of Viking Therapeutics⁵
• Jul 3, 2025Sold 4,266 shares at $27.76 of Viking Therapeutics⁶
• Jul 2, 2025Granted 7,667 shares of Viking Therapeutics⁶
• Jan 6, 2025Sold 4,700 shares at $43.32 of Viking Therapeutics⁷
• Jan 6, 2025Sold 45,609 shares at $42.69 of Viking Therapeutics⁷
• Jan 3, 2025Granted 21,667 shares of Viking Therapeutics⁷
• Jan 3, 2025Granted 44,533 shares of Viking Therapeutics⁷
• Oct 28, 2024Sold 1,206 shares at $81.44 of Viking Therapeutics⁸
• Oct 28, 2024Sold 7,967 shares at $80.65 of Viking Therapeutics⁸
• Oct 28, 2024Sold 6,050 shares at $79.78 of Viking Therapeutics⁸
• Oct 28, 2024Sold 15,825 shares at $78.69 of Viking Therapeutics⁸
• Oct 28, 2024Sold 23,082 shares at $77.68 of Viking Therapeutics⁸
• Oct 28, 2024Sold 9,265 shares at $76.94 of Viking Therapeutics⁸
• Oct 28, 2024Sold 18,620 shares at $75.79 of Viking Therapeutics⁸
• Oct 28, 2024Sold 49,672 shares at $74.56 of Viking Therapeutics⁸
• Oct 28, 2024Exercised options 51,000 shares at $8.52 of Viking Therapeutics⁸